Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canomiks is a genomics and AI-based technology company that provides product development and quality control solutions for the dietary supplement, functional food, and beverage industries. The company utilizes a proprietary platform to test the biological efficacy and safety of ingredients by measuring their impact on human gene expression. By integrating bioinformatics with artificial intelligence, Canomiks helps brands validate health claims, ensure batch-to-batch consistency, and mitigate regulatory risks. Their services enable the industry to move toward precision nutrition through scientifically backed ingredient transparency and rigorous biological validation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canomiks.